RTP Formulation & Sterile Fill-Finish Facility
More Content From RTP Formulation & Sterile Fill-Finish Facility
-
Pharmather Engages Alcami For Clinical And Commercial Manufacturing Of Novel Ketamine Products
Alcami to manufacture PharmaTher’s proprietary ketamine products for FDA Phase 3 clinical studies and global commercialization.News Releases Released on 11.08.2021
-
Alcami Announces Parenteral Operations Leadership Appointments
Chad Bovero, James Fife, and Tobin Cowart promoted to senior leadership team.News Releases Released on 11.08.2021
-
Alcami Expands Parenteral Operations With Additional Investment
A $31 million investment will expand its sterile development and manufacturing operation in Charleston, SC.News Releases Released on 11.08.2021
-
Alcami Appoints Timothy Compton As Chief Business Officer
25-year industry professional brings a track record of leading high-performing, client-centered business teams.News Releases Released on 11.08.2021
-
CASE STUDY: OSD FORMULATION DEVELOPMENT
Alcami used a Gerteis Mini-Pactor® roller compactor to develop a capsule formulation and critical processing parameters at the target dosage in record time.Case Studies Released on 11.08.2021
-
Host Cell Impurities, Bioassays, Micro-Flow Imaging
WHO, FDA and the European Pharmacopoeia have established strict regulatory guidelines to guarantee product quality in biologics.White Papers / Tech Papers Released on 06.28.2021
-
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s PFNTM program.News Releases Released on 06.28.2021
-
On-Demand Lab Open House
Sign up to get a close-up look at our US network of laboratories and hear about our expansion plans.News Releases Released on 06.28.2021
-
QBD Addresses API Supply in Orphan Drug Formulation
Due to the high costs and low demands of the drug product, it is important to efficiently use API supply during the formulation process.Case Studies Released on 06.28.2021
-
On-Demand Webinar: Microbial In-Use Studies
In this webinar, Alcami’s Brent Harlow will guide you through the necessity of these studies and how to successfully perform them for FDA approval.News Releases Released on 06.28.2021
-
Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer
He succeeds Walter J. Kaczmarek III, who is stepping down as Chief Executive Officer.News Releases Released on 03.18.2021
-
Pharmaceutical and Biotherapeutic Development and Testing
Formulation and Method Development.Literature / Brochures Released on 01.13.2021
-
Drug Product Development, Manufacturing, and Packaging
Parenteral Forms.Literature / Brochures Released on 01.11.2021
-
The Changing R&D Landscape
Emerging Technology Needs and Value Proposition for Strategic Partnerships with Contract Development and Manufacturing Organizations (CDMOs)White Papers / Tech Papers Released on 01.07.2021
